Hubungan Kadar Fibroblast Growth Factor 2 (FGF-2) Serum Dengan Derajat Meningioma Pada Penderita Meningioma Intrakranial Di RSUP. H. Adam Malik Medan

  

DAFTAR PUSTAKA

Al-Hadidy, A.M., Maani, W.S., Mahafza, W.S., Al-Najar, M.S., Al-Nadii, M.M. (2007).

  Intracranial Meningioma. J Med J 41(1):37-51. Al-Mefty, O., Abdulrauf, S.I., Haddad, G.F. 2011. Meningioma. In Youmans Neurological

  th Surgery , Winn HR (ed), 6 ed. New York: Elsevier. pp. 1426-1449.

  Al-Rodhan, N.R.F., Laws, E.R. 1991. The History of Intracranial Meningiomas. In Meningiomas, Al-Mefty (ed). New York: Raven Press. pp. 1-7. Arbeit, J.M., Olson, D.C., Hanahan, D. Upregulation Of Fibroblast Growth Factors And

  Their Receptors During Multi-Stage Epidermal Carcinogenesis In K14-HPV16 Transgenic Mice. (1996). Oncogene (13):1847-1857. Barnholtz-Sloan, J.S., Kruchko, C. 2007. Meningiomas: Causes and Risk Factors. Neurosurg Focus. 23 (4): E2. Bikfalvi, A., Klein, S., Pintucci, G., Quarto, N., Mignatti, P., Rifkin, D.B. Differential

  Modulation Of Cell Phenotype By Different Molecular Weight Form Of Basic Fibroblast Growth Factor: Possible Intracellular Signaling By The High Molecular Weight Form. (1995). J Cell Biol (129):233-243.

  Bikfalvi, A., Klein, S., Pintucci, G., Rifkin, D.B. Biological Roles of Fibroblast Growth Factor-2 (FGF-2). (1997). Endocr Rev (18):26-45. Black, P.M., Tariq, F. 2010. Biology Of Meningiomas. In: Pamir, M.N., Black, P.M.,

  Fahlbusch, Rudolf., Meningiomas, A Comprehensive Text. New York: Saunders Elsevier. pp. 121-125. Black, P.M., Villavicencio, A.T., Rhouddou, C.C., Loeffler, J.S. Aggressive Surgery and

  Focal Radiation in The Management of Meningiomas of The Skull Base: Preservation of Function with Maintanance of Local Control. Acta Neurochir. 2001:143(6):555-62. Calvocoressi, L., Claus, E.B. 2010. Epidemiology and Natural History of Meningioma. In: Pamir, M.N., Black, P.M., Fahlbusch, R., (eds). Meningiomas: A comprehensive text.

  New York: Saunders Elsevier. pp. 61-77. Cea-Soriano, L., Wallander, M.A., Garcia-Rodiquez, L.A., 2012. Epidemiology of meningioma in the United Kingdom. Neuroepidemiology 39 (1): 27-34.

  Cha, J.Y., Lambert, Q.T., Reuther, G.W., Der, C.J. Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis. Mol Cancer Res.

  2008(6):435-445. Chin, K., Devries, S., Fridlyand, J. Genomic and Transcriptional Aberations Linked To Breast Cancer Pathopysiologies. Cancer Cell. 2006(10):529-541. Chou, S.M., Miles, J.M. 1991. The Pathology of Meningiomas. In Meningiomas, Al-Mefty O(ed). New York: Raven Press. pp. 4:37-57. Choy, W., Kim, W., Nagasawa, D., Stramotas, S., Yew, A., Gopen, Q. 2011. The molecular

  genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments . Neurosurg Focus(ed6).pp.30.

  Christensen, H.C., Kosteljanetz, M.M., Johansen, C.C. Incidences of Gliomas and Meningiomas in Denmark, 1943 to 1997. Neurosurgery online. 2003;52(6):1327- 33;discussion 1333.

  Condra, K.S., Butti, J.M., Mendenhall, W.M., Friedman, W.A., Marcus, R.B., Rhoton, A.L.

  Benign Meningiomas: Primary Treatment Selection Affects Survival. Int J Radiat Oncol Biol Phys . 1997; 39(2):427-436. Denizot, Y., et al. Short Communication, The Quantitative Analysis of bFGF and VEGF by

  ELISA in Human Meningiomas. In: Mediators of Inflamation. Hindawi Publishing Corporation. Volume 2006, article ID 36376, pages 1-3.

  Evans, D.G.R., Watson, C., King, A., Wallace, A.J., Baser, M.E., 2005. Multiple meningiomas: differential involvement of the NF2 gene in children and adults. J Med

  Genet 42: 45-48.

  Ezzat, S., Zheng, L., Zhu, X.F., Wu, G.E., Asa, S.L. Targeted Expression of A Human Pituitary Tumor-Derived Isoform of FGF Reseptor-4 Recapitulates Pituitary Tumorigenesis. J Clin Invest. 2002; (109):69-78.

  Fisher, J.L., Schwartzbaum, J.A., Wrensch, M.W., Wiemels, J.L. Epidemiology of Brain Tumors. Neurol Clin. 2007; 25(4):867-890. Haugsten, E.M., Wiedlocha, A., Olsnes, S. Roles Of Fibroblast Growth Factor Receptors in Carcinogenesis. Mol Cancer Res. 2010; (8):1439-1452. Igaki H, Maruyama K, Koga T, et al. Stereotactic Radiosurgery for Skull Base Meningioma.

  Neurol Med Chir (Tokyo) . 2009; 49(10):456-461.

  Itoh, H., Hattori, Y., Sakamato, H. Preferential Alternative Splicing In Cancer Generates a K- sam messenger RNA with higher transforming activity. Cancer Res.1994; (54):3237- 3241. Juldich, P.J., Mc Carthy, B.J., Surawicz, T.S., Freels, S.S., Davis, F.G. Trends in Incidence of

  Primary Brain Tumors in United States, 1985-1994. Neuro-oncol. 2001; 3(3):141- 151. Klaeboe, L.L., Lonn, S.S., Scheie, D.D., et al. Incidence of Intracranial Meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer, 2005; 117(6):996- 1001.

  Krisch M, Santarius T, Black P. Molecular biology of meningiomas and peripheral nerve sheath tumors. Concepts Neurosurg, 1997; (8):126-45. Lai, R., Crevier, L., Thabane, L., 2005. Genetic polymorphisms of Glutathione S-

  Transferases and the risk of adult brain tumors: A meta-analysis. Cancer epidemiol biomarkers prev 14 (7): 1784-1790. Landriel, F., Black, P. 2012. Meningiomas. In: Ellenbogen, R., Abdulrauf, S., Sekhar, L.,

  Principles of Neurological Surgery. 3

  ed

  Li, V.W., Folkerth, R.D., Watanabe, H. Micovessel Count and Cerebrospinal Fluid Basic Fibroblast Growth Factor In Children With Brain Tumors. Lancet.1994; (344),82-86.

  . New York: Saunders Elsevier. pp. 541-564.

  Malmer, B., Feychting, M., Lonn, S., Ahlbom, A., Henriksson, R. 2005. Genotypes and risk of glioma and meningioma. Cancer epidemiol biomarkers prev 14 (9): 2220-2223. Marwin, C., Perry, A. 2010. Pathological Classification and Molecular Genetics of Meningiomas. J Neurooncol. 1999:379-391. Mathiesen, T.T., Lindquist, C.C., Kihlstrom, L.L., Karlsson, B.B. Recurrence of Cranial Base Meningiomas. Neurosurgery online. 1996; 39(1):2-7; discussion 8. McCarthy, B.J., Davis, F.G., Freels, S., et al. Factors Associated With Survival in Patients With Meningioma. J Neurosurg.1998; 88(5):831-839. Nakamura, M., Roser, F., Michel, J. The Natural History of Incidental Meningioma.

  Neurosurgery . 2003; (53):62-71.

  Nakamura, M.M., Roser, F.F., Michel, J.J., Jacobs, C.C., Samii, M.M. The Natural History of Incidental Meningiomas. Neurosurgery Online. 2003; 53(1):62-70; discussion 70. Otsuka S., Tamiya T., Ono Y., Michiue H., Kurozumi K., Daido S. 2004. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol. (70):349-357. Pietsch, T., Valter, M.M., Wolf, H.K., et al. Expression And Distribution Of Vascular Endothelial Growth Factor Protein In human Brain Tumors. Acta Neuropathologica.

  1997; 93(2):109-117. Radhakrisnan, K., Mokri, B., Parisi, J.E., O’Fallon, W.M., Sunku, J., Kurland, L.T. The

  Trends in Incidence of Primary Brain Tumors in the Population of Rochester, Minnesota. Ann Neurol. 1995; 37(1):67-73. Ragel, B.T., Couldwell, W.T., Gillespie, D.L., Wendland, M.M., Whang, K., Jensen, R.L. A Comparison of the cell lines used in meningioma research. Surg Neurol 2008; 70(3):295-307, discussion 307.

  Ragel BT, Jensen RL. Pathophysiology of meningiomas. Semin Neurosurg 2003; 85(9):169- 185. Rockhill, M., Rugala, M., Chamberlain, M.C. 2007. Intracranial Meningiomas: an overview of diagnosis and treatment. Neurosurg Focus 23 (4): 1-7. Sanmoto, K., Ikezaki, K., Ono, M. Expression of Vascular Endothelial Growth Factor And Its

  Possible Relation With Neovascularization In Human Brain Tumors. Cancer Research .1995; 55(5):1189-1193. Sav, A., Scheithauer, B.W. 2010. Neuropathology Of Meningiomas. In: Pamir, M.N., Black,

  P.M., Fahlbusch, Rudolf. Meningiomas, A Comprehensive Text. New York: Saunders Elsevier. pp. 99-119. Smith, M.J., Higgs, J.E., Bowers, N.L., Halliday, D., Paterson, J., Gillespie, J. 2011. Cranial meningiomas in 411 NF2 patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset. Journal of Medical Genetics 48: 1-22. Taghipour, M., Rakei, S.M., Monabati, A., Nahavandi-Nejad, M., 2007. The role of estrogen and progesterone receptors in grading of the malignancy of meningioma. IRCMJ 9

  (1): 17-21. Talacchi, A., Corsini, F., Gerosa, M., 2011. Hyperostosing meningiomas of the cranial vault with and without tumor mass. Acta neurochir 153: 53-61.

  Todo, T., Adams, E.F., Fahlbusch, R., Dingermann, T., Werner, H. Autocrine stimulation of human meningioma cells by platelet derived growth factor. J Neurosurg.1996; 84(5):852-8; discussion 858-859. Toyokawa, T., Yashiro, M., Hirakawa, K. Co-expression of Keratinocyte Growth Factor and

  K-sam is An Indepedent Prognostic Factor In Gastric Carcinoma. Oncol Rep. 2009; (21):875-880. Van Havenbergh, T., Carvalho, G., Tatagiba, M., Plets, C., Samii, M. Natural History of

Petroclival Meningiomas . Neurosurgery 2003; 52(1):55-62; discussion 62-74. Wang, J.L., Nister, M., Hermansson, M., Westermark, B., Ponten, J. Expression of PDGF beta-receptors in human meningioma cells. Int J Cancer. 1990; 46(5):772-778. Wei, Y., Jian, C., Golwa, F.H., Delin, X. Basic Fibroblast Growth Factor And Fibroblast Growth Factor Receptor-1 In Human Meningiomas. Journal of Huazhong University of Science and Technology . 2004; 24(1):75-77.

  Weisman, A.S., Villemure, J.G., Kelly, P.A. Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res. 1986: 46(5):2545-2550. Wiemels, J., Wrensch, M., Claus, E.B. 2010. Epidemiology and etiology of meningioma. J Neurooncol . 99 (3): 307-314. Wrensch, M.M., Minn, Y.Y., Chew, T.T., Bondy, M.M., Berger, M.S. Epidemiology of Brain

  Tumors: Current Concepts and Review of the Literature. Neuro oncol. 2002; 4(4):278-299.